glp 1 trials near me Care Access Real-World Evidence for GLP-1 Receptor
Description
- Laura M
Another phase 2 RCT studying semglutide 2.4 mg vs placebo in patients with compensated NASH cirrhosis did not show any statistically significant difference in NASH resolution or improvement in liver fibrosis between the groups
This means it binds to the same receptors the glucagon-like peptide-1 hormone normally binds to
PMID: 38351702
Nonetheless, in patients at high risk of sarcopenia, tailored management including nutritional optimization and concurrent resistance training should be considered to mitigate potential adverse consequences during pharmacologically induced weight loss [20]
